Previous 10 | Next 10 |
Three of the best-performing pharmaceutical stocks over the past year have been clinical-stage biotech and biopharmaceutical companies -- businesses that aren't making profits but have promising drugs, or more often, drug candidates. Though a few candidates will become breakout successes, the o...
CUPERTINO, Calif. , July 1, 2020 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced it has initiated recruiting patients for its randomized, double-blind, placebo-controlled, multi-center Phase 2 study to evaluate the safety and efficacy of DUR-928 in hospitalized CO...
CUPERTINO, Calif. , June 29, 2020 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced that it is set to join the broad-market Russell 3000 ® Index as a result of the 2020 Russell indexes annual reconstitution, effective after the US stock market opens today...
Intercept Pharmaceuticals (NASDAQ: ICPT ) -38% on FDA rejection of obeticholic acid in NASH. More news on: Intercept Pharmaceuticals, Inc., Cleveland BioLabs, Inc., China Jo-Jo Drugstores, Inc., Stocks on the move, , Read more ...
DURECT announces Gilead Sciences will terminate the License Agreement in July 2019, effective December 22, for the development and commercialization of a long-acting injectable HIV investigational product utilizing DURECT's SABER technology. More news on: DURECT Corporat...
CUPERTINO, Calif. , June 26, 2020 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced that Gilead Sciences, Inc., (Gilead) has provided notice that, effective as of December 22, 2020 , it is terminating the License Agreement dated July 19, 2019 and a related R&D agr...
Are These Penny Stocks On Your Biotech Watch List Right Now? When it comes to penny stocks , hot sectors can be constant sources of catalysts. One of the hottest right now has been biotech. We’re talking about one of the sectors of the stock market today that has been home to some of t...
Gainers: Ekso Bionics EKSO +138% . More news on: Puhui Wealth Investment Management Co., Ltd., Vaxart, Inc., PaySign, Inc., Stocks on the move, , Read more ...
CUPERTINO, Calif. , May 28, 2020 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) announced today that James E. Brown , President and CEO, will be presenting at the Jefferies 2020 Virtual Health Care Conference, Wednesday, June 3, 2020 at 10:00 a.m. EDT / 7:00 a.m. PDT . ...
CUPERTINO, Calif. , May 26, 2020 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced positive topline results from its Phase 1b clinical study of orally administered DUR-928 in nonalcoholic steatohepatitis (NASH) patients. A total of 65 patients completed the stu...
News, Short Squeeze, Breakout and More Instantly...
DURECT Corporation Receives FDA Breakthrough Therapy Designation for Larsucosterol in Alcohol-Associated Hepatitis PR Newswire DURECT plans to confirm the efficacy and safety of larsucosterol in a registrational Phase 3 clinical trial CUPERTINO, Calif. , May ...
A look at the top 10 most actives in the United States Faraday Future Intelligent Electric Inc. (FFIE) rose 171.6% to $0.1657 on volume of 180,907,472 shares AMC Entertainment Holdings Inc. Class A (AMC) rose 84.4% to $9.57 on volume of 174,658,682 shares Plug Power Inc. (PLUG) rose 45.9%...
DURECT Corporation Reports First Quarter 2024 Financial Results and Business Update PR Newswire - FDA Feedback Supports Single Pivotal Trial for Approval of Larsucosterol in Alcohol-Associated Hepatitis - Webcast of Ea...